BENDER ROBERT & ASSOCIATES - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
BENDER ROBERT & ASSOCIATES ownership history of EXELIXIS INC
ValueSharesWeighting
Q3 2021$1,236,000
-7.3%
58,469
-20.1%
0.35%
-6.6%
Q2 2021$1,334,000
-28.6%
73,215
-11.5%
0.38%
-36.9%
Q1 2021$1,869,000
+8.9%
82,730
-3.3%
0.60%
+10.1%
Q4 2020$1,717,000
-19.8%
85,545
-2.3%
0.55%
-28.8%
Q3 2020$2,142,000
+0.0%
87,590
-2.9%
0.77%
-9.3%
Q2 2020$2,141,000
+41.7%
90,170
+2.7%
0.85%
+5.1%
Q1 2020$1,511,000
-2.1%
87,760
+0.2%
0.80%
+15.7%
Q4 2019$1,543,000
-6.9%
87,560
-6.6%
0.70%
-16.0%
Q3 2019$1,658,000
-16.8%
93,765
-2.1%
0.83%
-12.3%
Q2 2019$1,993,000
-15.7%
95,810
-3.5%
0.94%
-18.4%
Q1 2019$2,364,000
+26.6%
99,325
+4.6%
1.16%
+7.4%
Q4 2018$1,868,000
-10.1%
94,945
-19.1%
1.08%
+14.1%
Q3 2018$2,078,000
-17.5%
117,290
+0.1%
0.94%
-28.5%
Q2 2018$2,520,000
+24.8%
117,120
+28.5%
1.32%
+17.9%
Q1 2018$2,019,00091,1651.12%
Other shareholders
EXELIXIS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 17,416,738$422,007,00064.06%
Matrix Capital Management Company, LP 15,117,460$366,296,00011.71%
Rhenman & Partners Asset Management AB 1,050,000$25,442,0003.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 254,334$6,163,0002.40%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 790,148$19,145,0001.30%
Jupiter Investment Management Ltd 4,182,760$101,348,0001.06%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 50,818$1,231,0000.70%
C M BIDWELL & ASSOCIATES LTD 17,475$423,0000.65%
QCM Cayman, Ltd. 9,562$232,0000.60%
Handelsinvest Investeringsforvaltning 98,500$2,387,0000.56%
View complete list of EXELIXIS INC shareholders